BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND BMPR1A, ACVRLK3, 657, ENSG00000107779, P36894, ALK3, CD292 AND Clinical Outcome
3 results:

  • 1. Asymptomatic pulmonary embolism in lung cancer: prevalence and analysis of clinical and radiological characteristics in 141 outpatients.
    Tiseo M; Bersanelli M; Pesenti Barili M; Bartolotti M; De Luca G; Gelsomino F; Camisa R; Cademartiri F; Ardizzoni A
    Tumori; 2012; 98(5):594-600. PubMed ID: 23235754
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial.
    Lee SM; Khan I; Upadhyay S; Lewanski C; Falk S; Skailes G; Marshall E; Woll PJ; Hatton M; Lal R; Jones R; Toy E; Chao D; Middleton G; Bulley S; Ngai Y; Rudd R; Hackshaw A; Boshoff C
    Lancet Oncol; 2012 Nov; 13(11):1161-70. PubMed ID: 23078958
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Reconstruction of chest wall after resection].
    Tan Z; Nirmal L; Liu D
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 May; 19(5):338-40. PubMed ID: 15960432
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.